ZHEJIANG XIDAMEN NEW MATERIAL CO., LTD. – Trademark Portfolio

Entity Type: 99

ZHEJIANG XIDAMEN NEW MATERIAL CO., LTD. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 24 (Fabrics) — 4 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include PERSILUX and BIOBLINDS. The owner is based in SHAOXING.

RUANGANG VILLAGE, LANTING TOWNSHIP,

SHAOXING 312046 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VELLANO
VELLANO
Abandoned 2025
BIOBLINDS
BIOBLINDS
Registered 2024
BIOBLINDS
BIOBLINDS
Registered 2024
PERSILUX
PERSILUX
Registered 2020

Trademark Classifications

ZHEJIANG XIDAMEN NEW MATERIAL CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

24
Fabrics (4 filings)

Textiles and textile goods; bed covers; table covers

Frequently Asked Questions

How many trademarks does ZHEJIANG XIDAMEN NEW MATERIAL CO., LTD. have?

ZHEJIANG XIDAMEN NEW MATERIAL CO., LTD. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.

What trademark classes does ZHEJIANG XIDAMEN NEW MATERIAL CO., LTD. file in?

ZHEJIANG XIDAMEN NEW MATERIAL CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 24 (Fabrics). Class 24 covers textiles and textile goods; bed covers; table covers.

What are ZHEJIANG XIDAMEN NEW MATERIAL CO., LTD.'s most well-known trademarks?

ZHEJIANG XIDAMEN NEW MATERIAL CO., LTD.'s registered trademark portfolio includes well-known marks such as PERSILUX and BIOBLINDS. These are among 3 currently registered trademarks in the portfolio.

What is ZHEJIANG XIDAMEN NEW MATERIAL CO., LTD.'s trademark registration success rate?

ZHEJIANG XIDAMEN NEW MATERIAL CO., LTD. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.